Chief Business Officer
CurrentAvistone is a global oncology company focused on targeted therapeutics for lung cancer. The Company has six assets under development.The Company has raised $340M through its Series A & B financing from investors including Vivo Capital, Bain Capital, Primavera Capital, SDIC, IDG, Yanchuang and Cathay Capital.